OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen — OpenAI announced a new series of AI models built to help life sciences researchers work faster.
Posted from: this blog via Microsoft Power Automate.